- Bloomberg•21 days ago
Lupin Ltd., India’s second-biggest drugmaker by market value, expects U.S. approvals for new products from its facility in the coastal state of Goa to begin again in the next two months as it addresses ...
- Bloomberg•4 months ago
Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs.
- Capital Cube•5 months ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Lupin Ltd.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day Moving AverageBearishRSI […] (Read more...) The post Lupin Ltd. breached its 50 day moving average in a Bearish Manner : 500257-IN : May 24, 2016 appeared first on CapitalCube.
Lupin Limited (LUPIN.BO)
BSE - BSE Delayed Price. Currency in INR
|Day's Range||1,493.25 - 1,518.00|
|52wk Range||1,294.05 - 2,096.30|
|1y Target Est||N/A|
|P/E Ratio (ttm)||26.27|
|Avg Vol (3m)||103,108|
|Dividend & Yield||N/A (N/A)|